MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $82,137,000 | +119.0% | 967,000 | +28.9% | 4.64% | +70.8% |
| Q3 2019 | $37,500,000 | +37.1% | 750,000 | 0.0% | 2.72% | +15.6% |
| Q2 2019 | $27,353,000 | +63.1% | 750,000 | +25.0% | 2.35% | +21.3% |
| Q1 2019 | $16,770,000 | +277.7% | 600,000 | +158.6% | 1.94% | +253.2% |
| Q4 2018 | $4,440,000 | -89.4% | 232,000 | -83.4% | 0.55% | -88.2% |
| Q3 2018 | $41,874,000 | -8.7% | 1,400,000 | +12.0% | 4.65% | -10.5% |
| Q2 2018 | $45,875,000 | +11.4% | 1,250,000 | 0.0% | 5.19% | +18.2% |
| Q1 2018 | $41,175,000 | +100.8% | 1,250,000 | +66.7% | 4.40% | +17.3% |
| Q4 2017 | $20,505,000 | -38.5% | 750,000 | -16.7% | 3.75% | -50.6% |
| Q3 2017 | $33,336,000 | -27.8% | 900,000 | -25.9% | 7.59% | -30.9% |
| Q2 2017 | $46,182,000 | -22.3% | 1,215,000 | 0.0% | 10.98% | -15.4% |
| Q1 2017 | $59,414,000 | +111.4% | 1,215,000 | +46.7% | 12.98% | +19.4% |
| Q4 2016 | $28,109,000 | +6.4% | 828,198 | +18.3% | 10.87% | -8.2% |
| Q3 2016 | $26,418,000 | – | 700,000 | – | 11.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |